Chorokbaem Healthcare Ownership
| 118000 Stock | 309.00 4.00 1.28% |
Chorokbaem |
Chorokbaem Stock Ownership Analysis
About 39.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 0.47. In the past many companies with similar price-to-book ratios have beat the market. Chorokbaem Healthcare had not issued any dividends in recent years. The entity had 1:10 split on the 13th of February 2014. For more info on Chorokbaem Healthcare Co please contact the company at 82 2 2186 1346 or go to https://www.wooridulls.co.kr.Chorokbaem Healthcare Outstanding Bonds
Chorokbaem Healthcare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Chorokbaem Healthcare uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Chorokbaem bonds can be classified according to their maturity, which is the date when Chorokbaem Healthcare Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Pair Trading with Chorokbaem Healthcare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chorokbaem Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chorokbaem Healthcare will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Chorokbaem Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chorokbaem Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chorokbaem Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chorokbaem Healthcare Co to buy it.
The correlation of Chorokbaem Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chorokbaem Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chorokbaem Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chorokbaem Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Chorokbaem Stock
Chorokbaem Healthcare financial ratios help investors to determine whether Chorokbaem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chorokbaem with respect to the benefits of owning Chorokbaem Healthcare security.